Literature DB >> 1822260

In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat.

S Milano1, C Simon, L Grélot.   

Abstract

We have studied the peripheral mechanisms responsible for the severe vomiting observed in cisplatin treated cats. Release of 5-hydroxytryptamine from isolated portions of the ileum and ileal tissue concentrations of 5-hydroxytryptamine were studied in vitro with control animals and animals previously treated with cisplatin. In the latter, two groups were observed: animals in which cisplatin (single dose, 10 mg/kg) induced vomiting within 4 h and animals that did not vomit within 4 h. Spectrofluorimetric assessment of 5-hydroxytryptamine in the perfusate and ileal tissue revealed that cisplatin increases both release, and tissue levels, of ileal 5-hydroxytryptamine in animals which vomited, whereas only ileal 5-hydroxytryptamine release was increased in animals which did not vomit. This may have clinical implications as cisplatin induced emesis may be more effectively prevented by drugs preventing ileal 5-hydroxytryptamine formation rather than release.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822260     DOI: 10.1007/BF01819832

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  24 in total

1.  Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

Authors:  V ERSPAMER; B ASERO
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

2.  Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat.

Authors:  G Bertaccini
Journal:  J Physiol       Date:  1960-09       Impact factor: 5.182

3.  Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

Authors:  G D Pratt; N G Bowery; G J Kilpatrick; R A Leslie; N M Barnes; R J Naylor; B J Jones; D R Nelson; J M Palacids; P Slater
Journal:  Trends Pharmacol Sci       Date:  1990-04       Impact factor: 14.819

4.  Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

Authors:  R Stables; P L Andrews; H E Bailey; B Costall; S J Gunning; J Hawthorn; R J Naylor; M B Tyers
Journal:  Cancer Treat Rev       Date:  1987-12       Impact factor: 12.111

5.  Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Authors:  L X Cubeddu; I S Hoffmann; N T Fuenmayor; A L Finn
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

6.  The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.

Authors:  J Hawthorn; K J Ostler; P L Andrews
Journal:  Q J Exp Physiol       Date:  1988-01

7.  Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy.

Authors:  L H Einhorn; C Nagy; K Werner; A L Finn
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

8.  A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group.

Authors:  S Kaasa; S Kvaløy; M A Dicato; F Ries; J V Huys; E Royer; L Carruthers
Journal:  Eur J Cancer       Date:  1990-03       Impact factor: 9.162

9.  The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.

Authors:  W L Smith; E M Callaham; R S Alphin
Journal:  J Pharm Pharmacol       Date:  1988-02       Impact factor: 3.765

10.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  3 in total

1.  Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus.

Authors:  F A Javid; R J Naylor
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.

Authors:  C P Schröder; W T van der Graaf; I P Kema; A Groenewegen; D T Sleijfer; E G de Vries
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  The role of serotonin as a mediator of emesis induced by different stimuli.

Authors:  A du Bois; H Kriesinger-Schroeder; H G Meerpohl
Journal:  Support Care Cancer       Date:  1995-09       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.